Hawaii attorney general sues maker of drug Plavix (Update)

March 19, 2014 by Jennifer Sinco Kelleher

Hawaii's attorney general is suing the makers of a widely prescribed blood thinner that he says a significant portion of the state's population has difficulty metabolizing.

Attorney General David Louie filed a lawsuit Wednesday against the manufacturers and distributors of Plavix, marketed to work similarly to aspirin to prevent a stroke or heart attack.

Louie says the drugmaker didn't disclose that Plavix would have diminished or no effect on people of East Asian and Pacific Islander ancestry. He says the drug puts them at risk for gastrointestinal bleeding and other complications.

The suit names Bristol-Myers Squibb and Sanofi-Aventis as defendants. In a joint statement, the companies said they won't comment on pending litigation.

Sanofi last year said the U.S. Justice Department was investigating its disclosures to the Food and Drug Administration about different responses to Plavix. It provided no details but said it was cooperating with the probe.

Explore further: FDA says heartburn drugs can interfere with Plavix

Related Stories

FDA says heartburn drugs can interfere with Plavix

November 17, 2009

(AP) -- Federal health officials said Tuesday a popular variety of heartburn medications can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart attack and stroke.

FDA extends Plavix patent by 6 months to May 2012

January 25, 2011

(AP) -- The makers of Plavix, the world's second best-selling medication, said Tuesday they will retain exclusive U.S. marketing rights to the blood thinner for an additional six months, under a decision by U.S. health regulators.

Genetic test for Plavix use may be unneeded: study

December 29, 2011

A new study published Wednesday cast doubt on the usefulness of a genetic test for patients taking the anti-coagulant drug Plavix, calling into question last year's FDA warning about the blood thinner.

Bristol-Myers, Sanofi revamp Plavix sales alliance (Update)

October 3, 2012

(AP)—Bristol-Myers Squibb Co. and France's Sanofi SA said Wednesday that they are restructuring their longtime partnership selling popular heart medications, now that their sales are plunging due to widespread competition ...

Recommended for you

Treatment options for opioid addiction are expanding

August 10, 2016

In the past two decades, the devastation associated with opioid addiction has escaped the relative confines of the inner city and extended to suburban and rural America. Due in large part to the proliferation of prescription ...

Can exercise be replaced with a pill?

October 2, 2015

Everyone knows that exercise improves health, and ongoing research continues to uncover increasingly detailed information on its benefits for metabolism, circulation, and improved functioning of organs such as the heart, ...

FDA bolsters warnings about class of antibiotics

July 26, 2016

(HealthDay)—The U.S. Food and Drug Administration announced Tuesday that it's strengthening label warnings on a class of antibiotics called fluoroquinolones because the drugs can lead to disabling side effects, including ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.